Kevin M. Tuffy, MS

Senior Scientist
AstraZeneca
Gaithersburg, Maryland, United States

Kevin joined AstraZeneca in 2017, and is now a Senior Scientist within the Translational Medicine group as part of the AstraZeneca Vaccines and Immune Therapies unit. Kevin currently leads a team that focuses on the monitoring of phenotypic resistance of viral variants, including SARS-CoV-2, through clinical exploratory and surveillance endpoints. Kevin received his MS in Biomedical Sciences from Pennsylvania State University in 2016 while studying the potential nuclear function of human immunodeficiency virus type 1 Gag protein.

Disclosure information not submitted.

Presentation(s):

• 185 - Nirsevimab Binding Site Conservation in RSV F Protein between 2019 and 2024: Analysis of Sequencing Data from the US OUTSMART-RSV Surveillance Study and Public Databases

  Monday, October 20, 2025
  2:45 PM - 2:57 PM US ET